Download CMV Real-TM Quant

Transcript
1. INTENDED USE
CMV Real-TM Quant PCR kit is an in vitro nucleic acid amplification test for qualitative
detection and quantification of human cytomegalovirus (CMV) DNA in the clinical materials
(peripheral blood plasma, amniotic fluid, cerebrospinal fluid (liquor), saliva, oropharyngeal
swabs, urine samples, bronchoalveolar lavage, whole human blood, white blood cells, and
viscera biopsy material) by using real-time hybridization-fluorescence detection.
The results of PCR analysis are taken into account in complex diagnostics of
disease.
2. PRINCIPLE OF PCR DETECTION
CMV determination by the polymerase chain reaction (PCR) with hybridization fluorescent
detection includes three stages: DNA extraction from clinical samples, PCR-amplification of
pathogen genome specific region, and real-time hybridization fluorescent detection. DNA is
extracted from peripheral blood plasma, amniotic fluid, cerebrospinal fluid (liquor), saliva,
oropharyngeal swabs, urine samples, bronchoalveolar lavage, whole human blood, white
blood cells, and viscera biopsy material in presence of Internal Control (IC), which allows
monitoring of analysis of each sample. Endogenous internal control (IC Glob - β-globin gene
DNA) allows monitoring of PCR analysis stages (DNA extraction and PCR amplification),
material sampling and storage adequacy. Then, CMV DNA is amplified using specific
primers and polymerase (TaqF).
β-globin gene DNA is a part of human genome DNA and it should be present in an adequate
amount in DNA sample, obtained from the cells. There must be no less than 20 000 genomes
per sample (DNA from 10 000 cells). Internal Control (IC), added during the sample
preparation from plasma, liquor, amniotic liquid, sputum, bronchial lavages and other cell
free or low in DNA content materials, serves as an amplification control for each individually
processed specimen and to identify possible reaction inhibition, while endogenous IC (βglobine gene), present in all samples obtained from cells (whole blood, leucocytes, biopsy
and autopsy material, saliva, swabs) allows not only to control analysis steps, but also to
estimate sample handling and storage.
In real-time PCR, the amplified product is detected using fluorescent dyes. These dyes are
linked to oligonucleotide probes which bind specifically to the amplified product during
thermocycling. The real-time monitoring of the fluorescence intensities during the real-time
PCR allows the detection of accumulating product without re-opening the reaction tubes after
the PCR run. CMV Real-TM Quant PCR kit uses “hot-start”, which greatly reduces the
frequency of nonspecifically primed reactions. “Hot-start” is guaranteed by separation of
nucleotides and Taq-polymerase by using a chemically modified polymerase (TaqF).
Chemically modified polymerase (TaqF) is activated by heating at 95 ºC for 15 min.
Sacace™ CMV Real-TM Quant
VER 11.11.2011